Refractive Errors Clinical Trial
Official title:
An Exploratory Study in Healthy Adult Volunteers to Evaluate the Best Corrected Visual Acuity (BCVA) Performance of a Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction
Verified date | August 2022 |
Source | EyeQue Corp. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is exploratory and examines whether the best-corrected visual acuities (BCVA's) from trial frames created with the refraction results obtained from a novel handheld optical device yields results similar to the ophthalmic refraction obtained from an autorefractor in healthy volunteers age stratum of 18 through 65 years.
Status | Recruiting |
Enrollment | 35 |
Est. completion date | June 21, 2023 |
Est. primary completion date | June 21, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Male or Female - Ages =>18 y.o. and =<65 y.o. - Binocular vision - Willing and able to give informed consent and follow all study procedures and requirements - Fluent in English Exclusion Criteria: - Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19. - Has traveled outside the country within the last 4 weeks. - At the discretion of the investigator: Age strata has achieved minimum evaluable population. - Spherical correction > +8 or < -10 - Using anticholinergic medications (including first-generation antihistamines) or other medications known to affect visual acuity within the greater of 3 days or 5 half-lives prior to enrolling in this study - Using an investigational drug or approved therapy for investigational use within the greater of 3 days or 5 half-lives prior to enrolling in this study - Has initiated any new medication in the past 2 weeks that, in the best medical judgment of the investigator, would impact their participation in the study or ability to use the EyeQue EQ103 device - Any self-reported mental illness or condition, including but not limited to: claustrophobia, fear of simulators, nyctophobia. - Any self-reported neurological diseases, including but not limited to: epilepsy, Alzheimer's, nystagmus Per subject self-reporting: eye disease, including but not limited to: - Glaucoma - Cataracts - Macular degeneration - Eye infection (by self-report or observation) - Keratoconus - Diabetic neuropathy/retinopathy - Cytomegalovirus retinitis - Color blindness (any color deficiency) - Diabetic macular edema - Amblyopia - Chronic or acute uveitis - Strabismus - Astigmatism > 3 diopters - Macular hole Subjects that: - Lack physical dexterity to properly operate the EyeQue device. - Lack the ability to follow instruction - Lack a command of the English language - Lack binocular vision - Are colorblind - Had eye surgery within the last 12 months (including Lasik) |
Country | Name | City | State |
---|---|---|---|
United States | EyeQue | Newark | California |
Lead Sponsor | Collaborator |
---|---|
EyeQue Corp. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Best corrected visual acuity (BCVA) for both eyes EQ103 vs Autorefractor for all participants | Tendency of, or achieving, statistical non-inferiority of EyeQue EQ103 BCVA's (reading an EDTRS chart) for each eye from (pooled) trial frames created with the refraction values compared with those of an autorefractor analyzed with all age groups. | Day 1 | |
Secondary | Best corrected visual acuity (BCVA) for both eyes EQ103 vs Autorefractor examining age groupings | Tendency of, or achieving, statistical non-inferiority of EyeQue EQ103 BCVA's (reading an EDTRS chart for each eye (pooled) from trial frames created with the refraction values compared with those of an autorefractor analyzed within the following age strata.
o Age Groups: 18 - 29, 30 - 44, 45 - 65 |
Day 1 | |
Secondary | Best corrected visual acuity (BCVA) for worse eye: EQ103 vs Autorefractor for all subjects and age groupings | Tendency of, or achieving, statistical non-inferiority of EyeQue EQ103 BCVA's (reading an EDTRS chart for worse eye from trial frames created with the refraction values compared with those of an autorefractor analyzed within the following age strata.
o Age Groups: All, 18 - 29, 30 - 44, 45 - 65 |
Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04532099 -
Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses
|
N/A | |
Completed |
NCT05039112 -
Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses
|
N/A | |
Completed |
NCT03670303 -
Trial of an Educational Intervention to Promote Spectacle Use Among Secondary School Children in Islamabad, Pakistan
|
N/A | |
Completed |
NCT02255474 -
Bifocal Lenses In Nearsighted Kids
|
N/A | |
Not yet recruiting |
NCT03222661 -
Direct Comparison of SVOne Obtained Refraction to Subjective Manifest Refraction
|
N/A | |
Completed |
NCT04055519 -
Clinical Performance Assessment of a Daily Wear Monthly Replacement Soft Silicone Hydrogel Contact Lens
|
N/A | |
Recruiting |
NCT05049070 -
Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction
|
N/A | |
Completed |
NCT04527978 -
Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 1
|
N/A | |
Completed |
NCT01430247 -
Vision Screening for the Detection of Amblyopia
|
N/A | |
Recruiting |
NCT06077682 -
Cycloplegic Refraction in Pediatric Patients With Esotropia
|
Phase 4 | |
Not yet recruiting |
NCT04077086 -
Correcting Myopia Among Secondary School Children to Increase Academic High School Attendance Rates in Rural Communities
|
N/A | |
Completed |
NCT04528017 -
Clinical Comparison of 2 Daily Disposable Contact Lenses - Pilot Study 2
|
N/A | |
Withdrawn |
NCT04352868 -
Customizing Myopia Control With Multifocal Toric Contact Lens
|
N/A | |
Recruiting |
NCT04338880 -
Academic Performance and Refractive Error
|
||
Recruiting |
NCT04545073 -
Outcomes of a Trifocal IOL in Post-refractive Patients
|
||
Enrolling by invitation |
NCT05992675 -
Air Optix® Night and Day® Aqua Continuous Wear
|
||
Enrolling by invitation |
NCT05976750 -
Air Optix® Night and Day® Aqua Daily Wear
|
||
Recruiting |
NCT06065631 -
Seeing to Learn in Sierra Leone
|
N/A | |
Not yet recruiting |
NCT05550740 -
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
|
N/A | |
Not yet recruiting |
NCT06044688 -
EyeQue VisionCheck 510(k) Clinical Trial
|
N/A |